skip to content

Trading statements

Accrol reports strong year of growth

16 May 2017 07:09

Independent tissue converter Accrol had a strong year of growth in its first year as a publicly listed business following its successful IPO on AIM in June 2016.

The company performed in line with market expectations despite some challenging macro-economic factors.

Over the last twelve months, Accrol consolidated its position as the leading supplier of tissue products to the discount sector and continued to invest in its growth plans with the opening of a new 168,000 square foot manufacturing facility in Leyland, Lancashire in January 2017. This increased production capacity to 143,000 tonnes per annum.

Accrol also agreed a 10-year lease with Orbit Developments on a 368,000 square foot warehouse in West Lancashire.

It said the warehouse will store finished goods and provide central distribution facilities to UK customers, enabling Accrol to simplify and consolidate existing warehouse facilities.

The company reported that warehouse management and national logistics will be contracted out to NFT.

Story provided by StockMarketWire.com

Related Company: ACRL

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

aew-banner-180x255.jpg -

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.